25 ноябр 2019
2Бронхиал астмани назорат қилишга эришишда антилейкотриен препаратларнинг ўрни
file.pdf
MAQOLA ANNOTATSIYASI
MUALIFLAR
Teglar
Maqolani baholang
0
Maqola idintifikatorlari
DOI:
Mavjud emas
Foydalanilgan adabiyotlar
1.Angelova-Fischer I., Tsankov N. // ActaDermatoven APA. – 2015. – Vol.14, N3. – P.115–119.
2.Anandan, C., Nurmatov, U., Van Schayck, O. C. P., & Sheikh, A. (2010). Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy, 65(2), 152-167.
3.Akdis, C. A., Akdis, M., Bieber, T., Bindslev‐Jensen, C., Boguniewicz, M., Eigenmann, P., ... & Luger, T. A. (2006). Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy, 61(8), 969-987.
4.Concha, D. R. L., & Arroyave, C. M. (2003). A leukotriene antagonist (montelukast) in the treatment of atopic dermatitis in pediatric patients. Revista alergia Mexico (Tecamachalco, Puebla, Mexico: 1993), 50(5), 187.
5.Reddel, H. K., Bateman, E. D., Becker, A., Boulet, L. P., Cruz, A. A., Drazen, J. M., ... & Lemanske, R. F. (2015). A summary of the new GINA strategy: a roadmap to asthma control. European Respiratory Journal, 46(3), 622-639.
6.Platts-Mills, T. A. (2015). The allergy epidemics: 1870-2010. Journal of Allergy and Clinical Immunology, 136(1), 3-13.